2096. Misbranding of bust developer.     U. S. v. Myrtle E. Edwards  (Elga Labo¬
ratories).     Plea of guilty.     Defendant plaeed on probation for 4 years.
(F. D. C. No. 2115.    Sample No. 5904-E.)
This product was falsely represented to be a "normalizing food" that would 
develop the bust. Its label failed to bear the common or usual name of each 
ingredient, and it contained undeclared color. 
On September 11, 1940, the United States attorney for the Northern District 
of California filed an information against Myrtle E. Edwards, trading as Elga 
Laboratories, at San Francisco, Calif., alleging shipment on or about January 
29, 1940, from the State of California into the State of Ohio of a quantity of 
Elga Bust Developer that was misbranded.
The article was alleged to be misbranded in that the statements, "Elga Bust 
Developer. A Specialized normalizing Food designed to suppliment nature, 
feeding systemically the sensitive, delicate, starved cells of immature, sagging 
or depleted breasts," borne on the bottle label were false and misleading in 
that they represented that the article would develop the bust; that it was a 
specialized normalizing food designed to supplement nature; and that it would 
feed systemically the sensitive, delicate, starved cells of immature, sagging, or 
depleted breasts; whereas it would not be effective for such purposes. It was 
alleged to be misbranded further in that it was fabricated from two or more 
ingredients, and its label did not bear the common or usual name of each of
such ingredients; and in that it contained artificial coloring and did not bear 
labeling stating that fact.
The article was also alleged to be misbranded under the provisions of the 
law applicable to drugs, as reported in D. D. N. J. No. 370.
On February 4, 1941, a plea of guilty having been entered, the court placed 
the defendant on probation for a period of 4 years.